XT
IART icon

XTX Topco’s Integra LifeSciences IART Stock Holding History

XTX Topco’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,774
Closed -$311K – 2132
2024
Q1 		$311K Buy
+8,774
New +$351K 0.04% 823
2023
Q3 		– Sell
-10,965
Closed -$451K – 1760
2023
Q2 		$451K Buy
+10,965
New +$528K 0.08% 435
2022
Q2 		– Sell
-3,861
Closed -$248K – 963
2022
Q1 		$248K Buy
+3,861
New +$254K 0.11% 333
2021
Q4 		– Sell
-3,175
Closed -$217K – 831
2021
Q3 		$217K Buy
+3,175
New +$224K 0.07% 470
2021
Q2 		– Sell
-4,044
Closed -$279K – 936
2021
Q1 		$279K Buy
+4,044
New +$274K 0.14% 304

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

XTX Topco's IART Position: Q2 2024 in Review

XTX Topco sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 8,774 shares — an estimated $311K sold.

XTX Topco first reported a position in IART in Q1 2021 and held it in 5 quarters. The position peaked at $451K in Q2 2023. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • XTX Topco reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • XTX Topco sold 8,774 Integra LifeSciences shares in Q2 2024, an estimated $311K.
  • XTX Topco first reported a position in Integra LifeSciences in Q1 2021 and held it in 5 quarters.
  • XTX Topco's Integra LifeSciences position peaked at $451K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.